2021-005999-18Ongoing
Effect of obesity on COX1 and 2 acetylation by aspirin as a biomarker of its efficacy in colon cancer chemoprevention and therapy.
Instituto de Investigación Sanitaria AragónEU Clinical Trials Register
VerifiedEU Clinical Trials Register
Study focus
- Disease/Condition
- Colorectal cancer
Sponsor & location
- Primary sponsor
- Instituto de Investigación Sanitaria Aragón
- Funder
- Instituto de Salud Carlos III
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
-Allergy to acetylsalicylic acid or other NSAIDs.
ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2021-005999-18
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2021-005999-18 through Pure Global AI's free database. This phase not specified trial is sponsored by Instituto de Investigación Sanitaria Aragón and is currently Ongoing. The study focuses on Colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.